Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction

Abstract The new European Society of Cardiology guidelines reclassified heart failure according to left ventricular ejection fraction (LVEF), recognizing patients with mid-range EF [(mrEF), 40-49%)] as a distinct group. We sought to investigate the clinical profile, in-hospital outcomes and long ter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2017-07, Vol.120 (2), p.186-190
Hauptverfasser: Margolis, Gilad, MD, Khoury, Shafik, MD, Ben-Shoshan, Jeremy, MD, PhD, Letourneau-Shesaf, Sevan, MD, Flint, Nir, MD, Keren, Gad, MD, Shacham, Yacov, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 190
container_issue 2
container_start_page 186
container_title The American journal of cardiology
container_volume 120
creator Margolis, Gilad, MD
Khoury, Shafik, MD
Ben-Shoshan, Jeremy, MD, PhD
Letourneau-Shesaf, Sevan, MD
Flint, Nir, MD
Keren, Gad, MD
Shacham, Yacov, MD
description Abstract The new European Society of Cardiology guidelines reclassified heart failure according to left ventricular ejection fraction (LVEF), recognizing patients with mid-range EF [(mrEF), 40-49%)] as a distinct group. We sought to investigate the clinical profile, in-hospital outcomes and long term mortality of ST elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) who had mrEF. We conducted a retrospective study of 2086 consecutive STEMI patients between December 2007 and June 2016 who underwent primary PCI and had a comprehensive echocardiographic examination performed within 72 h of hospital admission. Patients were stratified according to their LVEF – mrEF (40-49%), reduced EF [(rEF), 50%] groups and evaluated for baseline characteristics, in-hospital outcomes, as well as for long term mortality. A total of 858/2086 (41%) patients had mrEF, 215/2086 (10%) had rEF and 1013/2086 (48%) had pEF. Patients with mrEF had nearly similar baseline co-morbidities and similar 30-day mortality compared to patients with pEF (2% vs.1%, p=0.17). In a univariate analysis, long term mortality was higher compared with those with pEF (9.8%vs. 7.2%, p
doi_str_mv 10.1016/j.amjcard.2017.04.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1901752678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914917306938</els_id><sourcerecordid>1911184731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-256e17e49b0f73628a4b4ed5c753b357126c48d16baf5976698659459150df723</originalsourceid><addsrcrecordid>eNqFkttuEzEQhlcIREPhEUCWuOFmF8-uD-sbUFWlJVIqIlLg0nK8s8HLHoK9qZSn4JXrbQJIvUGy5IO--Wc8_yTJa6AZUBDvm8x0jTW-ynIKMqMso5Q_SWZQSpWCguJpMqOU5qkCps6SFyE08QrAxfPkLC95kUvJZ8nvlR-2_RBGZ8mi27XOmtENfSBDTW5clX4x_RbJEuuRfMN-9M7uW-PJvEE7ceTKm-MhrlUMjUwgK48hHly_Jd_d-IOsb1Oyxm0X38i8xbuHFOTmMEz1O9OSRV8b_6DzMnlWmzbgq9N-nny9mt9efkqXn68XlxfL1DJWjmnOBYJEpja0loXIS8M2DCtuJS82BZeQC8vKCsTG1FxJIVQpuGJcAadVLfPiPHl31N354dcew6g7Fyy2relx2AcNKnaV50KWEX37CG2Gve9jdZECgJLJAiLFj5T1Qwgea73zrjP-oIHqyTHd6JNjenJMU6ajYzHuzUl9v-mw-hv1x6IIfDwCGNtx59DrYGObLVbORxN0Nbj_pvjwSMG2ro9Otz_xgOHfb3TINdXraWymqQFZUKGKsrgHgjG-jA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911184731</pqid></control><display><type>article</type><title>Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Margolis, Gilad, MD ; Khoury, Shafik, MD ; Ben-Shoshan, Jeremy, MD, PhD ; Letourneau-Shesaf, Sevan, MD ; Flint, Nir, MD ; Keren, Gad, MD ; Shacham, Yacov, MD</creator><creatorcontrib>Margolis, Gilad, MD ; Khoury, Shafik, MD ; Ben-Shoshan, Jeremy, MD, PhD ; Letourneau-Shesaf, Sevan, MD ; Flint, Nir, MD ; Keren, Gad, MD ; Shacham, Yacov, MD</creatorcontrib><description>Abstract The new European Society of Cardiology guidelines reclassified heart failure according to left ventricular ejection fraction (LVEF), recognizing patients with mid-range EF [(mrEF), 40-49%)] as a distinct group. We sought to investigate the clinical profile, in-hospital outcomes and long term mortality of ST elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) who had mrEF. We conducted a retrospective study of 2086 consecutive STEMI patients between December 2007 and June 2016 who underwent primary PCI and had a comprehensive echocardiographic examination performed within 72 h of hospital admission. Patients were stratified according to their LVEF – mrEF (40-49%), reduced EF [(rEF), &lt;40%], and preserved EF [(pEF), &gt; 50%] groups and evaluated for baseline characteristics, in-hospital outcomes, as well as for long term mortality. A total of 858/2086 (41%) patients had mrEF, 215/2086 (10%) had rEF and 1013/2086 (48%) had pEF. Patients with mrEF had nearly similar baseline co-morbidities and similar 30-day mortality compared to patients with pEF (2% vs.1%, p=0.17). In a univariate analysis, long term mortality was higher compared with those with pEF (9.8%vs. 7.2%, p&lt;0.01). In a multivariate Cox regression model mrEF was independently associated with increased long term mortality risk compared with pEF (Hazard ratio 1.4, 95% CI 1.02-1.93, P =0.04). In conclusion, among STEMI patients, those with mrEF at presentation constitute a distinct group in terms of baseline characteristics, in-hospital outcomes and long term mortality.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2017.04.005</identifier><identifier>PMID: 28532775</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Cardiovascular disease ; Echocardiography ; Ejection fraction ; Electrocardiography ; Female ; Health risk assessment ; Heart ; Heart attacks ; Heart diseases ; Heart failure ; Humans ; Intervention ; Israel - epidemiology ; Laboratories ; Male ; Medical prognosis ; Mortality ; Myocardial infarction ; Patients ; Prognosis ; Regression analysis ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; ST Elevation Myocardial Infarction - diagnosis ; ST Elevation Myocardial Infarction - mortality ; ST Elevation Myocardial Infarction - physiopathology ; Stroke Volume - physiology ; Survival Rate - trends ; Time Factors ; Ventricle ; Ventricular Function, Left - physiology</subject><ispartof>The American journal of cardiology, 2017-07, Vol.120 (2), p.186-190</ispartof><rights>Elsevier Inc.</rights><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul 15, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-256e17e49b0f73628a4b4ed5c753b357126c48d16baf5976698659459150df723</citedby><cites>FETCH-LOGICAL-c448t-256e17e49b0f73628a4b4ed5c753b357126c48d16baf5976698659459150df723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914917306938$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28532775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Margolis, Gilad, MD</creatorcontrib><creatorcontrib>Khoury, Shafik, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Jeremy, MD, PhD</creatorcontrib><creatorcontrib>Letourneau-Shesaf, Sevan, MD</creatorcontrib><creatorcontrib>Flint, Nir, MD</creatorcontrib><creatorcontrib>Keren, Gad, MD</creatorcontrib><creatorcontrib>Shacham, Yacov, MD</creatorcontrib><title>Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Abstract The new European Society of Cardiology guidelines reclassified heart failure according to left ventricular ejection fraction (LVEF), recognizing patients with mid-range EF [(mrEF), 40-49%)] as a distinct group. We sought to investigate the clinical profile, in-hospital outcomes and long term mortality of ST elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) who had mrEF. We conducted a retrospective study of 2086 consecutive STEMI patients between December 2007 and June 2016 who underwent primary PCI and had a comprehensive echocardiographic examination performed within 72 h of hospital admission. Patients were stratified according to their LVEF – mrEF (40-49%), reduced EF [(rEF), &lt;40%], and preserved EF [(pEF), &gt; 50%] groups and evaluated for baseline characteristics, in-hospital outcomes, as well as for long term mortality. A total of 858/2086 (41%) patients had mrEF, 215/2086 (10%) had rEF and 1013/2086 (48%) had pEF. Patients with mrEF had nearly similar baseline co-morbidities and similar 30-day mortality compared to patients with pEF (2% vs.1%, p=0.17). In a univariate analysis, long term mortality was higher compared with those with pEF (9.8%vs. 7.2%, p&lt;0.01). In a multivariate Cox regression model mrEF was independently associated with increased long term mortality risk compared with pEF (Hazard ratio 1.4, 95% CI 1.02-1.93, P =0.04). In conclusion, among STEMI patients, those with mrEF at presentation constitute a distinct group in terms of baseline characteristics, in-hospital outcomes and long term mortality.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Echocardiography</subject><subject>Ejection fraction</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Intervention</subject><subject>Israel - epidemiology</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Myocardial infarction</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>ST Elevation Myocardial Infarction - diagnosis</subject><subject>ST Elevation Myocardial Infarction - mortality</subject><subject>ST Elevation Myocardial Infarction - physiopathology</subject><subject>Stroke Volume - physiology</subject><subject>Survival Rate - trends</subject><subject>Time Factors</subject><subject>Ventricle</subject><subject>Ventricular Function, Left - physiology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkttuEzEQhlcIREPhEUCWuOFmF8-uD-sbUFWlJVIqIlLg0nK8s8HLHoK9qZSn4JXrbQJIvUGy5IO--Wc8_yTJa6AZUBDvm8x0jTW-ynIKMqMso5Q_SWZQSpWCguJpMqOU5qkCps6SFyE08QrAxfPkLC95kUvJZ8nvlR-2_RBGZ8mi27XOmtENfSBDTW5clX4x_RbJEuuRfMN-9M7uW-PJvEE7ceTKm-MhrlUMjUwgK48hHly_Jd_d-IOsb1Oyxm0X38i8xbuHFOTmMEz1O9OSRV8b_6DzMnlWmzbgq9N-nny9mt9efkqXn68XlxfL1DJWjmnOBYJEpja0loXIS8M2DCtuJS82BZeQC8vKCsTG1FxJIVQpuGJcAadVLfPiPHl31N354dcew6g7Fyy2relx2AcNKnaV50KWEX37CG2Gve9jdZECgJLJAiLFj5T1Qwgea73zrjP-oIHqyTHd6JNjenJMU6ajYzHuzUl9v-mw-hv1x6IIfDwCGNtx59DrYGObLVbORxN0Nbj_pvjwSMG2ro9Otz_xgOHfb3TINdXraWymqQFZUKGKsrgHgjG-jA</recordid><startdate>20170715</startdate><enddate>20170715</enddate><creator>Margolis, Gilad, MD</creator><creator>Khoury, Shafik, MD</creator><creator>Ben-Shoshan, Jeremy, MD, PhD</creator><creator>Letourneau-Shesaf, Sevan, MD</creator><creator>Flint, Nir, MD</creator><creator>Keren, Gad, MD</creator><creator>Shacham, Yacov, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170715</creationdate><title>Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction</title><author>Margolis, Gilad, MD ; Khoury, Shafik, MD ; Ben-Shoshan, Jeremy, MD, PhD ; Letourneau-Shesaf, Sevan, MD ; Flint, Nir, MD ; Keren, Gad, MD ; Shacham, Yacov, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-256e17e49b0f73628a4b4ed5c753b357126c48d16baf5976698659459150df723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Echocardiography</topic><topic>Ejection fraction</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Intervention</topic><topic>Israel - epidemiology</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Myocardial infarction</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>ST Elevation Myocardial Infarction - diagnosis</topic><topic>ST Elevation Myocardial Infarction - mortality</topic><topic>ST Elevation Myocardial Infarction - physiopathology</topic><topic>Stroke Volume - physiology</topic><topic>Survival Rate - trends</topic><topic>Time Factors</topic><topic>Ventricle</topic><topic>Ventricular Function, Left - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Margolis, Gilad, MD</creatorcontrib><creatorcontrib>Khoury, Shafik, MD</creatorcontrib><creatorcontrib>Ben-Shoshan, Jeremy, MD, PhD</creatorcontrib><creatorcontrib>Letourneau-Shesaf, Sevan, MD</creatorcontrib><creatorcontrib>Flint, Nir, MD</creatorcontrib><creatorcontrib>Keren, Gad, MD</creatorcontrib><creatorcontrib>Shacham, Yacov, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Margolis, Gilad, MD</au><au>Khoury, Shafik, MD</au><au>Ben-Shoshan, Jeremy, MD, PhD</au><au>Letourneau-Shesaf, Sevan, MD</au><au>Flint, Nir, MD</au><au>Keren, Gad, MD</au><au>Shacham, Yacov, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2017-07-15</date><risdate>2017</risdate><volume>120</volume><issue>2</issue><spage>186</spage><epage>190</epage><pages>186-190</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Abstract The new European Society of Cardiology guidelines reclassified heart failure according to left ventricular ejection fraction (LVEF), recognizing patients with mid-range EF [(mrEF), 40-49%)] as a distinct group. We sought to investigate the clinical profile, in-hospital outcomes and long term mortality of ST elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) who had mrEF. We conducted a retrospective study of 2086 consecutive STEMI patients between December 2007 and June 2016 who underwent primary PCI and had a comprehensive echocardiographic examination performed within 72 h of hospital admission. Patients were stratified according to their LVEF – mrEF (40-49%), reduced EF [(rEF), &lt;40%], and preserved EF [(pEF), &gt; 50%] groups and evaluated for baseline characteristics, in-hospital outcomes, as well as for long term mortality. A total of 858/2086 (41%) patients had mrEF, 215/2086 (10%) had rEF and 1013/2086 (48%) had pEF. Patients with mrEF had nearly similar baseline co-morbidities and similar 30-day mortality compared to patients with pEF (2% vs.1%, p=0.17). In a univariate analysis, long term mortality was higher compared with those with pEF (9.8%vs. 7.2%, p&lt;0.01). In a multivariate Cox regression model mrEF was independently associated with increased long term mortality risk compared with pEF (Hazard ratio 1.4, 95% CI 1.02-1.93, P =0.04). In conclusion, among STEMI patients, those with mrEF at presentation constitute a distinct group in terms of baseline characteristics, in-hospital outcomes and long term mortality.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28532775</pmid><doi>10.1016/j.amjcard.2017.04.005</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2017-07, Vol.120 (2), p.186-190
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1901752678
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Cardiology
Cardiovascular
Cardiovascular disease
Echocardiography
Ejection fraction
Electrocardiography
Female
Health risk assessment
Heart
Heart attacks
Heart diseases
Heart failure
Humans
Intervention
Israel - epidemiology
Laboratories
Male
Medical prognosis
Mortality
Myocardial infarction
Patients
Prognosis
Regression analysis
Retrospective Studies
Risk Factors
Severity of Illness Index
ST Elevation Myocardial Infarction - diagnosis
ST Elevation Myocardial Infarction - mortality
ST Elevation Myocardial Infarction - physiopathology
Stroke Volume - physiology
Survival Rate - trends
Time Factors
Ventricle
Ventricular Function, Left - physiology
title Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST- Segment Elevation Myocardial Infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A49%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Implications%20of%20Mid-Range%20Left%20Ventricular%20Ejection%20Fraction%20on%20Patients%20Presenting%20With%20ST-%20Segment%20Elevation%20Myocardial%20Infarction&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Margolis,%20Gilad,%20MD&rft.date=2017-07-15&rft.volume=120&rft.issue=2&rft.spage=186&rft.epage=190&rft.pages=186-190&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2017.04.005&rft_dat=%3Cproquest_cross%3E1911184731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911184731&rft_id=info:pmid/28532775&rft_els_id=S0002914917306938&rfr_iscdi=true